Landmark Study Finds Cannabis Use Pushes Back the Age Psychosis Begins

Person in a plaid shirt sitting down with hands clutching their head in distress, depicting mental health struggles related to cannabis use and psychosis.

A sweeping new analysis of more than 180 studies has confirmed what clinicians have long suspected. Cannabis use and psychosis onset move together, and the link grows stronger with age. The study appeared in Biological Psychiatry. It pooled data from 18,272 cannabis users and 52,801 non users across 149 studies. As a result, it stands as the largest quantitative review of its kind to date.

The Scale of the Evidence

Researchers at the University of New South Wales led the work. They found that cannabis users developed psychosis on average two and a half years earlier than non users. This headline figure sits alongside an already substantial body of research. Reporting in Psychiatric Times has separately noted that cannabis users carry a 1.4 fold increased risk of any psychotic outcome. That figure rises to a 2.1 fold increase among the most frequent users. Meanwhile, a related synthesis of ten studies and 66,810 participants found even steeper odds. Heavy users faced a four fold increase in risk compared with people who had never used cannabis at all. Cannabis induced psychosis, in other words, has moved from a clinical hypothesis to a documented and repeatedly replicated pattern.

Why Timing Matters

This study broke results down by the age at which psychosis began, something earlier reviews had not done. Cannabis made no measurable difference to onset age when illness began before twenty. However, among adults whose psychosis began between twenty and twenty four, cannabis users lost 1.60 years. The gap widened to 4.43 years for those whose illness began between twenty five and twenty nine. It reached 6.30 years for adults whose psychosis began at thirty or older. Researchers therefore link this rising pattern to cumulative exposure over time rather than a single adolescent window of vulnerability. The finding held firm under scrutiny. Scientists calculated that 5771 further studies showing no effect would be needed to overturn the result, a bar the authors call very high.

What Happens in the Brain

Separate imaging research offers a biological explanation. Scientists used neuromelanin sensitive MRI to study the brain’s dopamine system. They found an elevated signal in the midbrain of people with cannabis use disorder. That signal grew stronger again in those who had also developed first episode schizophrenia. Dopamine dysregulation sits at the centre of the leading model of psychosis. Consequently, the imaging findings point to a plausible mechanism. Sustained cannabis exposure could disrupt the very system that regulates perception and reward. The effect looked dose dependent as well. Heavier cannabis use tracked with a stronger neuromelanin signal. This echoes a dose response relationship already seen in earlier epidemiological work on psychosis risk.

Testimony from the Courtroom

The pattern has surfaced outside the laboratory. Yale psychiatrist Dr Deepak D’Souza addressed a recent federal hearing into cannabis rescheduling. He called marijuana a cause of psychosis and schizophrenia. The link, he told the court, has been studied for two centuries. Furthermore, he placed cannabis abuse potential above that of LSD or MDMA. Emergency physician Dr Karen Randall gave evidence from her own caseload. She described marijuana as a hallucinogen capable of derailing a young life. Her list included psychosis, cannabis use disorder and lasting changes to brain pathways. Treatment beds for young people facing cannabis related psychosis risk remain scarce, she said, particularly when schizophrenia is also present.

A Question of Public Health

None of this proves that cannabis causes psychosis in every case. The study authors acknowledge that a bidirectional relationship cannot be ruled out. Shared genetic vulnerability may also play a part. Even so, the pattern held across five times as many studies as the last major review. It also survived the removal of outlying results largely unchanged. Therefore, that consistency gives the association real weight. For families and clinicians alike, the practical message is simple. Every extra year before psychosis onset gives a person more time to finish education and build a career. It also helps put support networks in place. Cannabis is becoming more available in more places. As a result, the case for clear headed conversations about cannabis use and psychosis has rarely looked stronger.


Sources:

Leave a Reply

Your email address will not be published.